Department of Oral and Maxillofacial surgery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Department of Research, Arka Education and Clinical Research Consultants, Tehran, Iran; Universal Network of Interdisciplinary Research in Oral and Maxillofacial Surgery (UNIROMS), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Am J Infect Control. 2021 Sep;49(9):1165-1176. doi: 10.1016/j.ajic.2021.03.008. Epub 2021 Mar 24.
The COVID-19 pandemic raises an urgent need for large-scale control through easier, cheaper, and safer diagnostic specimens, including saliva and sputum. We aimed to conduct a systemic review and meta-analysis on the reliability and sensitivity of SARS-CoV-2 detection in saliva and deep throat sputum (DTS) compared to nasopharyngeal, combined naso/oropharyngeal, and oropharyngeal swabs.
This systematic review and meta-analysis was performed according to the PRISMA statement. The inclusion criteria were studies that specifically assessed a sample of saliva or DTS with at least one other respiratory specimen in patients with COVID-19 infection, based on RT-PCR tests. The DerSimonian-Laird bivariate random-effects model analysis performed using STATA software with the "metaprop" package.
From 1598 studies, we retrieved 33 records, of which 26 studies were included for quantitative analysis. We found an overall sensitivity of 97% (95% confidence interval [CI], 86-100) for bronchoalveolar lavage fluid, 92% (95% CI, 80-99) for double naso/oropharyngeal swabs, 87% (95% CI, 77-95) for nasopharyngeal swabs, 83% (95% CI, 77-89) for saliva, 82% (95% CI, 76-88) for DTS, and 44% (95% CI, 35-52) for oropharyngeal swabs among symptomatic patients, respectively. Regardless of the type of specimens, the viral load and sensitivity in the severe patients were higher than mild and in the symptomatic patients higher than asymptomatic cases.
The present review provides evidence for the diagnostic value of different respiratory specimens and supports saliva and DTS as promising diagnostic tools for first-line screening of SARS-CoV-2 infection. However, the methods of sampling, storing, and laboratory assay need to be optimized and validated before introducing as a definitive diagnosis tool. Saliva, DTS, and nasopharyngeal swab showed approximately similar results, and sensitivity was directly related to the disease severity. This review revealed a relationship between viral load, disease severity, and test sensitivity. None of the specimens showed appropriate diagnostic sensitivity for asymptomatic patients.
新冠疫情大流行迫切需要通过更简单、更廉价和更安全的诊断样本进行大规模控制,包括唾液和痰液。本研究旨在对唾液和深喉痰(DTS)与鼻咽、鼻咽/口咽联合拭子和口咽拭子相比,检测 SARS-CoV-2 的可靠性和灵敏度进行系统评价和荟萃分析。
本系统评价和荟萃分析按照 PRISMA 声明进行。纳入标准为专门评估 COVID-19 感染患者唾液或 DTS 样本与至少一种其他呼吸道样本的研究,采用 RT-PCR 检测。采用 STATA 软件和“metaprop”包进行 DerSimonian-Laird 双变量随机效应模型分析。
从 1598 项研究中,我们检索到 33 条记录,其中 26 项研究纳入定量分析。我们发现支气管肺泡灌洗液的总体灵敏度为 97%(95%置信区间 [CI],86-100),双鼻咽/口咽拭子为 92%(95% CI,80-99),鼻咽拭子为 87%(95% CI,77-95),唾液为 83%(95% CI,77-89),DTS 为 82%(95% CI,76-88),口咽拭子为 44%(95% CI,35-52),分别为症状性患者。无论标本类型如何,重症患者的病毒载量和灵敏度均高于轻症患者,症状性患者高于无症状患者。
本综述为不同呼吸道标本的诊断价值提供了证据,并支持唾液和 DTS 作为 SARS-CoV-2 感染一线筛查的有前途的诊断工具。然而,在引入作为明确诊断工具之前,需要优化和验证采样、储存和实验室检测方法。唾液、DTS 和鼻咽拭子的结果大致相似,灵敏度与疾病严重程度直接相关。本综述揭示了病毒载量、疾病严重程度和检测灵敏度之间的关系。在无症状患者中,没有任何一种标本具有适当的诊断敏感性。